Herpes Markers Testing Market

Herpes Markers Testing Market Outlook (2024 to 2034)

The global herpes markers testing market size is predicted to rise at a CAGR of 6.1% and reach US$ 817.5 million by 2034. Due to the increasing incidence of herpes infection, the market for herpes marker testing is anticipated to develop significantly and reach US$ 452.9 million in 2024.

The robust pipeline and active research and development activities are expected to provide excellent growth potential for the global herpes marker testing market. These elements will create numerous chances for market participants to leverage and develop their businesses between 2024 and 2034.

Key Market Growth Drivers

• The rising prevalence of HSV-1 and HSV-2, the herpes simplex virus, drives the need for herpes marker testing. Based on the research of the Public Health Agency of Canada, the seroprevalence of HSV-1 infection is about 100% in undeveloped and underdeveloped countries and above 70% in industrialized countries worldwide.
• The herpes virus is quite common and causes no symptoms, so the market for herpes marker testing is expanding. Since over 80% of herpes infections have no symptoms, doctors must rely on diagnostic testing to diagnose accurately and provide the appropriate therapy.
• Testing for the herpes simplex virus (HSV), formerly done manually, has progressed to automated labs employing sophisticated equipment, including chemical analyzers, enabling more precise and efficient testing techniques. The usage of these techniques drives the global market for herpes testing.
• The herpes marker testing market is experiencing significant growth due to the increasing demand for this diagnostic tool in research clinics worldwide. Accurate detection of herpes markers is crucial for scientists and healthcare professionals, and the market is expected to continue expanding due to technological advancements.

The global market for therapies for the illness is expected to rise primarily owing to the growing prevalence of sexually transmitted diseases and viable pipeline prospects. It is anticipated that this expansion will support the herpes markers testing sector.

Report Attributes	Details
Estimated Market Value (2024E)	US$ 452.9 million
Forecasted Market Value (2034F)	US$ 817.5 million
Global Market Growth Rate (2024 to 2034)	6.1% CAGR
Antibody Based Kits Segment Growth Rate (2024 to 2034)	6.1%
HSV-1/HSV-2 Segment Growth Rate (2024 to 2034)	6.5%
North America Market Share (2024)	29.7%
East Asia Market Share (2024)	8.6%
Key Companies Profiled	Abbott Laboratories Abcam Plc Thermo Fisher Scientific F. Hoffmann-La Roche Ltd. DiaSorin S.p.A. Quidel Corporation Luminex Corporation Merck KGaA Qiagen N.V. Norgen Biotek Corp. Hologic Inc. Bio Rad Laboratories Inc. Meridian Bioscience Inc Teco Diagnostics BioMaerieux SA

Which Factors Have Driven the Global Surge in the Herpes Markers Testing Industry?

“Rising Occurrence of Hospital-Acquired Infections Erupts the Herpes Markers Testing Industry”

Individuals with long-term or chronic illnesses, such as encephalitis and keratitis, are at a heightened risk of contracting the Herpes simplex virus, which can lead to elevated rates of Human immunodeficiency virus (HIV) transmission and acquisition.

The Herpes simplex virus, causing painful blisters and cold sores, necessitates efficient treatment options. The herpes markers testing market focuses on developing diagnostic tests to detect viral antibodies in blood samples. As herpes infections increase globally, demand for these tests is expected to upsurge.

“Growing Rate of Herpes Simplex Virus Fuels Market Expansion”

Neonatal herpes is a potentially fatal condition that can arise from a new-born being exposed to HSV in the vaginal system during delivery. The rising birth rate is advantageous to the market since new-born herpes can cause permanent neurological damage or even infant mortality. It is anticipated that the number of new infections, the rise of clinical research, and technical improvements will propel the market for herpes simplex virus (HSV) testing.

Nonetheless, during the projection period, the herpes simplex virus (HSV) testing market will have more growth opportunities due to the development of precise screening tests and the expansion of the healthcare sector.

Which Factors Present Challenges to the Herpes Markers Testing Market Growth?

“Lack of Awareness towards STD Treatment Spoils Herpes Markers Testing Market Growth”

The global herpes marker testing market is expected to face significant challenges due to stringent government regulations likely to hinder market growth. Additionally, the social stigma attached to sexually transmitted illnesses is a significant barrier to the market's expansion, which is further compounded by increased product recalls.

The scarcity of qualified workers and the restricted availability of labs are two significant obstacles impeding the maturation of the herpes simplex virus (HSV) testing industry. This is anticipated to considerably limit the market's growth throughout the forthcoming decade.

Despite the increasing demand for herpes marker testing, the limited availability of testing facilities and trained professionals pose significant challenges to the market's growth.

Country-wise Insights

The herpes relief sector in North America is predicted to develop at a phenomenal annual pace of 6.3% by 2034. It is expected that 73.6% of the United States industry will be accounted for by quick herpes testing in 2024.

In the meanwhile, it is projected that by 2034, the market for sexually transmitted diseases in East Asia will grow at a 5.9% CAGR. With a 49.0% market share, China is expected to command most of East Asia’s herpes marker testing market in 2024.

Why is the United States Dominating the Global Herpes Markers Testing Market?

“Rise in Clinical Trials for STDs Burgeons the United States Herpes Markers Testing Industry”

According to Fact.MR., the demand for herpes testing is expected to grow remarkably in the United States. It is projected to reach a market size of approximately US$ 99 million in 2024. Moreover, a CAGR of 6.4% is expected during the forecast period, which is likely to result in a market worth US$ 184 million by 2034. This reflects a significant expansion in the herpes testing market, indicating a growing need for reliable and accurate disease diagnosis.

When it comes to clinical studies on herpes marker testing, the United States is leading the industry. Modern testing facilities and medical insurance coverage for HSV testing are two other features that set the area apart.

Significant income from the region's share of the global herpes marker testing market is also attributed to the high awareness among people to seek medical testing for symptomatic HSV. The increased severity of Herpes and the increasing number of HIV patients are two further factors driving the rise of the herpes marker testing industry in the United States.

Which Factors Position China as a Thriving Herpes Diagnosis Industry?

“Limited Public Awareness Pushes Chinese Healthcare Sector with Sluggish Pace”

China’s herpes marker testing industry is expected to increase and reach a predicted value of US$ 35 million by 2034. In 2024, it is anticipated that China will account for 49.0% of the East Asian market for herpes markers testing. The market has been expanding gradually in the last few years. From 2024 to 2034, this sector is projected to grow at a 6.2% CAGR.

The public's ignorance of the virus persists in developing nations such as China, severely hindering the herpes marker testing industry. Due to this lack of knowledge, there is little demand for herpes diagnostic testing and little money made.

Public education about the virus is made much more difficult because the issue is exacerbated by a shortage of medical resources and an unstable economy in many locations. As a result, the demand for accessible and trustworthy herpes diagnostic tests that may aid in the early diagnosis of the virus and stop its transmission is developing in large cities such as Beijing and Macao. It is critical to address this issue so that individuals in China may obtain appropriate care, understand the hazards of HSV, and take the necessary steps to protect themselves and others.

Category-wise Insights

The test type of antibody-based kits is predicted to account for 50.2% of the market in 2024. Concurrently, the viral culture test sector would attain 26.0% of the market, considerably augmenting the industry's resource variety and stability.

Preliminary data suggests that in 2024, the HSV-1/HSV-2 segment will have a 48.9% market share for herpes markers testing. In 2024, the HSV-2 category is expected to hold a 27.6% market share and grow at an average annual increase of 5.7%.

Why Is the Herpes Markers Testing Industry Increased Demand for Antibody Based Kits?

“Demand for the Antibody Based Kits Cures the Herpes Markers Testing Industry”

Antibody-based kits dominated the market in 2024 with a 50.2% revenue share. Over the following decade, the antibody-based kits category is expected to increase most rapidly, with an overall growth rate of 6.1%. The category of antibody-based Kits had a valuation of US$ 227.5 million in 2024.

The demand for antibody-based kits in the herpes markers testing market is rising due to the increased necessity for precise and effective diagnostic tools. These kits are essential for identifying herpes indicators and giving medical personnel a trustworthy way to recognize and treat herpes infections.

The rising use of antibody-based tests is partly due to greater awareness of STDs and the need for early detection. Because of their ease of use, sensitivity and specificity are essential for raising test accuracy, supporting prompt treatments, and improving patient outcomes. This growing demand highlights how important antibody-based kits are to advancing herpes diagnoses.

Competitive Landscape

The demand for herpes treatments is expected to rise due to industry players investing in research and development, expanding their product offerings, and strategic initiatives like new product launches, mergers, acquisitions, higher investment, and collaborations. The herpes markers testing industry must offer reasonably priced products to survive in a competitive market.

Major treatment manufacturers aim to increase sales and global demand for their STD medicines by obtaining FDA clearance and collaborating with regional distribution partners. Local manufacturing is a critical business approach in the global herpes treatment industry, reducing operational costs, benefiting consumers, and increasing market share.

• In October 2023, Gilead Sciences and Assembly Biosciences collaborated to discover new antiviral treatments, initially concentrating on Assembly Bio's well-established areas of hepatitis B, HDV, and herpesviruses.
• In August 2023, David Chu and Uma Singh from the University of Georgia developed and patented a chemical that could potentially treat varicella-zoster virus, herpes-causing shingles, and chickenpox.

Segmentation of Herpes Markers Testing Market

• By Test Type:

  • Viral Culture Test
  • Nucleic Acid Amplification Based Kits
  • Antibody Based Kits

• By Indication:

  • HSV-1
  • HSV-2
  • HSV-1/HSV-2

• By Application:

  • Research Use
  • Clinical Diagnostics

• By End User:

  • Hospitals
  • Diagnostics Centers
  • Clinics
  • Academic & Research Institutes

• By Region:

  • North America
  • Europe
  • East Asia
  • East Asia
  • South Asia & Oceania
  • Middle East & Africa